histamine has been researched along with Bleb in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study was undertaken to study the ability of substance P (SP) to induce inositol phospholipid (IP) hydrolysis measured as inositol mono-phosphate (IP1) accumulation, in an in vivo blister model of neurogenic inflammation in the rat hind footpad." | 7.67 | Substance P induced hydrolysis of inositol phospholipids in rat skin in an in vivo model of inflammation. ( Andrews, PV; Helme, RD; Khalil, Z; Thomas, KL, 1989) |
| "Significantly more HRF was found in blister fluids from lesional skin of patients with CU as compared with nonlesional skin and skin of control subjects." | 5.29 | Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. ( Bédard, PM; Brunet, C; Claveau, J; Hébert, J; Lavoie, A, 1993) |
| "The present study was undertaken to study the ability of substance P (SP) to induce inositol phospholipid (IP) hydrolysis measured as inositol mono-phosphate (IP1) accumulation, in an in vivo blister model of neurogenic inflammation in the rat hind footpad." | 3.67 | Substance P induced hydrolysis of inositol phospholipids in rat skin in an in vivo model of inflammation. ( Andrews, PV; Helme, RD; Khalil, Z; Thomas, KL, 1989) |
| "Terfenadine is a safe non-sedative H1-receptor antagonist." | 2.67 | Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine. ( Lush, M; Marks, R; Newcombe, RG; Shall, L, 1991) |
| "Mizolastine is a new non-sedative antihistamine and antiallergic drug proven to be effective and safe in the treatment of allergic rhinitis and urticaria." | 1.31 | Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine. ( Dubertret, L; Jean-Louis, F; Levy, D; Michel, L; Murrieta-Aguttes, M, 2000) |
| "Skin blisters were induced on the forearms and challenged with allergen or phosphate-buffered saline (PBS)." | 1.30 | Allergen-induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of interleukin-4 and sVCAM-1. ( Alkner, U; Fernvik, E; Grönneberg, R; Halldén, G; Lundahl, J; Raud, J; van Hage-Hamsten, M, 1999) |
| "Significantly more HRF was found in blister fluids from lesional skin of patients with CU as compared with nonlesional skin and skin of control subjects." | 1.29 | Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. ( Bédard, PM; Brunet, C; Claveau, J; Hébert, J; Lavoie, A, 1993) |
| "Antihistamine activity was assessed as the post-treatment percentages of changes in the histamine-induced relative wheal and flare areas versus baseline." | 1.29 | Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine. ( Bianchetti, G; Chosidow, O; Danjou, P; Dubruc, C; Espagne, E; Fuseau, E; Herson, S; Revuz, J; Rosenzweig, P; Thenot, JP, 1996) |
| "The histamine concentration was measured from suction blister fluid obtained from normal and lesional skin of 8 patients with fixed drug eruption (FDE) caused by phenazone salicylate and from that of 2 healthy control subjects." | 1.28 | Suction blister fluid histamine in fixed drug eruption. ( Alanko, K; Reitamo, S; Salo, OP; Stubb, S, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cochrane, DE | 1 |
| Carraway, RE | 1 |
| Miller, LA | 1 |
| Feldberg, RS | 1 |
| Bernheim, H | 1 |
| OSWIECIMSKA, H | 1 |
| SHAPOSHNIKOV, OK | 1 |
| Kandhari, KC | 1 |
| Bhide, NK | 1 |
| Sood, VK | 1 |
| Claveau, J | 1 |
| Lavoie, A | 1 |
| Brunet, C | 1 |
| Bédard, PM | 1 |
| Hébert, J | 1 |
| Chosidow, O | 1 |
| Dubruc, C | 1 |
| Danjou, P | 1 |
| Fuseau, E | 1 |
| Espagne, E | 1 |
| Bianchetti, G | 1 |
| Thenot, JP | 1 |
| Herson, S | 1 |
| Rosenzweig, P | 1 |
| Revuz, J | 1 |
| Fernvik, E | 1 |
| Halldén, G | 1 |
| Lundahl, J | 1 |
| Raud, J | 1 |
| Alkner, U | 1 |
| van Hage-Hamsten, M | 1 |
| Grönneberg, R | 1 |
| Michel, L | 1 |
| Murrieta-Aguttes, M | 1 |
| Jean-Louis, F | 1 |
| Levy, D | 1 |
| Dubertret, L | 1 |
| Alanko, K | 1 |
| Stubb, S | 1 |
| Salo, OP | 1 |
| Reitamo, S | 1 |
| Shall, L | 1 |
| Newcombe, RG | 1 |
| Lush, M | 1 |
| Marks, R | 1 |
| Thomas, KL | 1 |
| Andrews, PV | 1 |
| Khalil, Z | 1 |
| Helme, RD | 1 |
| Tandon, GS | 1 |
| Shukla, RC | 1 |
| Benjamin, S | 1 |
| Peachey, RD | 1 |
| McKee, WD | 1 |
| Cochrane, CG | 1 |
| Farr, RS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of the Measurement of Substance P in the Saliva of Patients With Low Back Pain[NCT00735735] | 40 participants (Actual) | Interventional | 2009-02-28 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for histamine and Bleb
| Article | Year |
|---|---|
Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Topics: Adult; Benzhydryl Compounds; Blister; Dose-Response Relationship, Drug; Double-Blind Method; Erythem | 1991 |
Effect of bradykinin and its antagonists on superficial and deep pain in human subjects and dogs.
Topics: Acetylcholine; Animals; Arachnida; Aspirin; Blister; Bradykinin; Clinical Trials as Topic; Codeine; | 1966 |
12 other studies available for histamine and Bleb
| Article | Year |
|---|---|
Histamine releasing peptide (HRP) has proinflammatory effects and is present at sites of inflammation.
Topics: Animals; Blister; Chemotaxis; Collagen; Edema; Histamine; Inflammation; Mast Cells; Mice; Oligopepti | 2003 |
[Histamine blister in scarlet fever].
Topics: Blister; Histamine; Humans; Scarlet Fever | 1953 |
[Role of histamine and of histamine-like substances in the mechanism of capillary permeability disorders in the development of bullous elements].
Topics: Blister; Capillary Permeability; Histamine; Humans | 1958 |
Role of some biologically active substances in the mechanism of blister formation.
Topics: Acetylcholine; Blister; Burns; Cantharidin; Epidermolysis Bullosa; Erythema Multiforme; Herpes Zoste | 1967 |
Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis.
Topics: Adult; Basophils; Biomarkers, Tumor; Blister; Chronic Disease; Female; Histamine; Histamine Release; | 1993 |
Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
Topics: Administration, Oral; Adult; Benzimidazoles; Blister; Body Water; Histamine; Histamine H1 Antagonist | 1996 |
Allergen-induced accumulation of eosinophils and lymphocytes in skin chambers is associated with increased levels of interleukin-4 and sVCAM-1.
Topics: Adult; Allergens; alpha-Macroglobulins; Asthma; Blister; Eosinophils; Female; Flow Cytometry; Histam | 1999 |
Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
Topics: Adolescent; Adult; Allergens; Antibody Formation; Benzimidazoles; Blister; Cell Adhesion; Cross-Over | 2000 |
Suction blister fluid histamine in fixed drug eruption.
Topics: Adolescent; Adult; Aged; Antipyrine; Blister; Drug Eruptions; Exudates and Transudates; Female; Hist | 1992 |
Substance P induced hydrolysis of inositol phospholipids in rat skin in an in vivo model of inflammation.
Topics: Animals; Blister; Capillary Permeability; Capsaicin; Histamine; Hydrolysis; Inflammation; Phosphatid | 1989 |
Skin temperature and blood flow in relation to the speed of suction blister formation.
Topics: Adult; Aged; Atmospheric Pressure; Blister; Cold Temperature; Constriction; Dilatation; Epinephrine; | 1971 |
A clinical study of an unusual case of asthma associated with urticaria pigmentosa.
Topics: Asthma; Blister; Child, Preschool; Chlorpheniramine; Codeine; Histamine; Humans; Male; Methysergide; | 1966 |